Dual Inhibition of TRIP13 and Aurora A Induces Mitotic DNA Damage and Concurrent Pyroptotic-Apoptotic Cell Death in...

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cancers with lost tumor suppressor function lack targeted therapies.
• Understanding cell cycle mechanisms is crucial for developing new cancer treatments.

Purpose of the Study:

• Investigate co-targeting TRIP13 and Aurora A in Rb-deficient cancers.
• Define mechanisms for effective treatment strategies.

Main Methods:

• Live-cell imaging, apoptosis, pyroptosis, and cell cycle assays in vitro.
• In vivo studies using Aurora A inhibitor and TRIP13 degradation in mouse xenografts.
• Analysis of human tumor mRNA expression.

Main Results:

• Dual targeting induced prolonged mitotic arrest, leading to mitotic cell death.
• Combination therapy enhanced cytotoxicity by extending mitotic arrest and inducing DNA damage.
• Rb-deficient cancers experienced both apoptotic and pyroptotic cell death.
• Significant anti-tumor efficacy and survival benefit observed in vivo.
• Human tumors showed adaptive mechanisms to pyroptosis that were overcome by the combination.

Conclusions:

• Combined inhibition of TRIP13 and Aurora A shows therapeutic potential.
• The strategy induces mitotic pyroptosis and apoptosis in Rb-deficient cancer cells.
• Potential to engage anti-tumor immunity for enhanced therapeutic index.